Written question asked by Lord Mann (Labour) on Tuesday, 29 October 2002, in the House of Commons. It was due for an answer on Thursday, 7 November 2002. It was answered by Hazel Blears (Labour) on Thursday, 7 November 2002 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what guidelines have been given to (a) pharmacists and (b) primary care trusts to ensure that biological drugs are kept within recognised safe temperatures during storage and transport to patients.

Answer: John Mann: To ask the Secretary of State for Health what guidelines have been given to (a) pharmacists and (b) primary care trusts to ensure that biological drugs are kept within recognised safe temperatures during storage and transport to patients. [78491] Ms Blears: The Medicines Control Agency (MCA), an executive agency of the Department of Health, regulates medicinal products for human use in the United Kingdom on behalf of the UK Licensing Authority. UK legislation places an obligation on licensed manufacturers, distributors and importers of medicinal products to exercise control over the distribution chain to ensure that the medicinal products are handled, stored and distributed under the necessary conditions to avoid deterioration of the products. The Royal Pharmaceutical Society of Great Britain's code of ethics and standards and practice guidance provides guidance to UK registered pharmacists on the storage of medicines under controlled temperatures.

Secondary information

Type: Written question
Reference: 392 c534W;392 c546W; 78491
Session: 2001-02
Subjects: Drugs Pharmacy Prescription drugs Primary care trusts Transport Storage Safety
Link: View this Written question on www.publications.parliament.uk